Planch Root Extract Suppresses the Growth and Metastasis of Hypopharyngeal Carcinoma by Inhibiting E2F Transcription Factor 1-mediated MNX1 Antisense RNA 1

Overview

Journal Bioengineered

Date 2022 Feb 14

PMID 35152841

Authors

Yi Zheng

Lizhong Su

Jun Tan

Feilin Dong

Affiliations

Soon will be listed here.

Abstract

Increasing evidence has shown that traditional Chinese medicines and their bioactive components exert an anti-tumor effect, representing a novel treatment strategy. Planch Root extracts (acRoots) have been reported to repress cancer cell proliferation and metastasis. The effect of acRoots on hypopharyngeal carcinoma progression was explored in this study. Firstly, data from MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) and colony formation assays showed that incubation with accRoots reduced cell proliferation of hypopharyngeal carcinoma cells. Moreover, acRoots promoted the cell apoptosis of hypopharyngeal carcinoma. Secondly, cell migration and invasion of hypopharyngeal carcinoma cells were suppressed by acRoots. Thirdly, E2F1 (E2F Transcription Factor 1) and lncRNA MNX1-AS1 (MNX1 antisense RNA 1) were up-regulated in hypopharyngeal carcinoma tissues, and reduced in hypopharyngeal carcinoma cells post acRoots incubation. Overexpression of E2F1 attenuated acRoots-induced decrease in MNX1-AS1 in hypopharyngeal carcinoma cells. Lastly, administration with acRoots retarded in vivo hypopharyngeal carcinoma growth through down-regulation of E2F1-mediated MNX1-AS1. In conclusion, acRoots exerted tumor-suppressive role in hypopharyngeal carcinoma through inhibition of E2F1-mediated MNX1-AS1.

Citing Articles

Genome-wide identification of kiwifruit K channel Shaker family members and their response to low-K stress.

Zi Y, Zhang Z, Zhao K, Yang X, Zhu L, Yin T BMC Plant Biol. 2024; 24(1):833.

PMID: 39243055 PMC: 11378538. DOI: 10.1186/s12870-024-05555-x.

Current concepts of the crosstalk between lncRNA and E2F1: shedding light on the cancer therapy.

Huang P, Wen F, Li Q Front Pharmacol. 2024; 15:1432490.

PMID: 39119602 PMC: 11306149. DOI: 10.3389/fphar.2024.1432490.

Mechanisms of Actinidia chinensis Planch in treating colon cancer based on the integration of network pharmacology, molecular docking, and experimental verification.

Chen J, Wu S, Shi Z, Qu Y, Ding M, Hu B Hereditas. 2023; 160(1):39.

PMID: 38102686 PMC: 10722835. DOI: 10.1186/s41065-023-00303-x.

Exploring the anticancer potential of Actinidia chinensis Planch root extracts () on hepatocellular carcinoma: A molecular mechanism study.

Qiu K, Xia Q, Chen H, Ye Q, Mao H, Tian M Heliyon. 2023; 9(11):e21851.

PMID: 38027882 PMC: 10656260. DOI: 10.1016/j.heliyon.2023.e21851.

Full-length transcriptome analysis of (Roxb.) DC.

Zhu Y, Huang Y, Wei K, Yu J, Jiang J PeerJ. 2023; 11:e15321.

PMID: 37163151 PMC: 10164372. DOI: 10.7717/peerj.15321.

References

Mu Y, Sa N, Yu L, Lu S, Wang H, Xu W . Epithelial cell adhesion molecule is overexpressed in hypopharyngeal carcinoma and suppresses the metastasis and proliferation of the disease when downregulated. Oncol Lett. 2014; 8(1):175-182. PMC: 4063652. DOI: 10.3892/ol.2014.2140. View

Qi F, Zhao L, Zhou A, Zhang B, Li A, Wang Z . The advantages of using traditional Chinese medicine as an adjunctive therapy in the whole course of cancer treatment instead of only terminal stage of cancer. Biosci Trends. 2015; 9(1):16-34. DOI: 10.5582/bst.2015.01019. View

Gao Z, Deng G, Li Y, Huang H, Sun X, Shi H . Actinidia chinensis Planch prevents proliferation and migration of gastric cancer associated with apoptosis, ferroptosis activation and mesenchymal phenotype suppression. Biomed Pharmacother. 2020; 126:110092. DOI: 10.1016/j.biopha.2020.110092. View

Hoffman R, Li C, He K, Wu X, He B, He T . Chinese Herbal Medicine and Its Regulatory Effects on Tumor Related T Cells. Front Pharmacol. 2020; 11:492. PMC: 7186375. DOI: 10.3389/fphar.2020.00492. View

Huang Y, Zhu H, Ji X, Chen Y, Zhang Y, Huang R . TBX3 knockdown suppresses the proliferation of hypopharyngeal carcinoma FaDu cells by inducing G1/S cell cycle arrest and apoptosis. Oncol Lett. 2020; 19(1):113-120. PMC: 6923984. DOI: 10.3892/ol.2019.11089. View

Fang T, Fang Y, Xu X, He M, Zhao Z, Huang P . Actinidia chinensis Planch root extract attenuates proliferation and metastasis of hepatocellular carcinoma by inhibiting epithelial-mesenchymal transition. J Ethnopharmacol. 2018; 231:474-485. DOI: 10.1016/j.jep.2018.11.014. View

Gao L, Wang X, Niu Y, Duan D, Yang X, Hao J . Molecular targets of Chinese herbs: a clinical study of hepatoma based on network pharmacology. Sci Rep. 2016; 6:24944. PMC: 4855233. DOI: 10.1038/srep24944. View

Zhu W, Yu D, Zhao M, Lin M, Lu Q, Wang Q . Antiangiogenic triterpenes isolated from Chinese herbal medicine Actinidia chinensis Planch. Anticancer Agents Med Chem. 2012; 13(2):195-8. DOI: 10.2174/1871520611313020002. View

Liu X, Yang Q, Yan J, Zhang X, Zheng M . LncRNA MNX1-AS1 promotes the progression of cervical cancer through activating MAPK pathway. J Cell Biochem. 2018; 120(3):4268-4277. DOI: 10.1002/jcb.27712. View

10.

Wang Z, Wei P, Wei D, Cao S, Liu H, Chen L . Effect of up-regulation of circMATR3 on the proliferation, metastasis, progression and survival of hypopharyngeal carcinoma. J Cell Mol Med. 2020; 24(8):4687-4697. PMC: 7176838. DOI: 10.1111/jcmm.15134. View

11.

Mou S, Zhou Z, He Y, Liu F, Gong L . Curcumin inhibits cell proliferation and promotes apoptosis of laryngeal cancer cells through Bcl-2 and PI3K/Akt, and by upregulating miR-15a. Oncol Lett. 2017; 14(4):4937-4942. PMC: 5649612. DOI: 10.3892/ol.2017.6739. View

12.

Wang L, Hou J, Wang J, Zhu Z, Zhang W, Zhang X . Regulatory roles of HSPA6 in Actinidia chinensis Planch. root extract (acRoots)-inhibited lung cancer proliferation. Clin Transl Med. 2020; 10(2):e46. PMC: 7403824. DOI: 10.1002/ctm2.46. View

13.

Zhao Y, Liu Y . A mechanistic overview of herbal medicine and botanical compounds to target transcriptional factors in Breast cancer. Pharmacol Res. 2018; 130:292-302. DOI: 10.1016/j.phrs.2017.12.027. View

14.

Lee T, Kim O, Kim Y, Lim J, Kim S, Park J . Quercetin arrests G2/M phase and induces caspase-dependent cell death in U937 cells. Cancer Lett. 2005; 240(2):234-42. DOI: 10.1016/j.canlet.2005.09.013. View

15.

Chu J, Li H, Xing Y, Jia J, Sheng J, Yang L . LncRNA MNX1-AS1 promotes progression of esophageal squamous cell carcinoma by regulating miR-34a/SIRT1 axis. Biomed Pharmacother. 2019; 116:109029. DOI: 10.1016/j.biopha.2019.109029. View

16.

Guo R, Zou B, Liang Y, Bian J, Xu J, Zhou Q . LncRNA RCAT1 promotes tumor progression and metastasis via miR-214-5p/E2F2 axis in renal cell carcinoma. Cell Death Dis. 2021; 12(7):689. PMC: 8270952. DOI: 10.1038/s41419-021-03955-7. View

17.

Petersen J, Timmermans A, van Dijk B, Overbeek L, Smit L, Hilgers F . Trends in treatment, incidence and survival of hypopharynx cancer: a 20-year population-based study in the Netherlands. Eur Arch Otorhinolaryngol. 2017; 275(1):181-189. PMC: 5754418. DOI: 10.1007/s00405-017-4766-6. View

18.

Brito A, Ribeiro M, Abrantes A, Pires A, Teixo R, Tralhao J . Quercetin in Cancer Treatment, Alone or in Combination with Conventional Therapeutics?. Curr Med Chem. 2015; 22(26):3025-39. DOI: 10.2174/0929867322666150812145435. View

19.

Vageli D, Doukas S, Sasaki C . Inhibition of NF-B prevents the acidic bile-induced oncogenic mRNA phenotype, in human hypopharyngeal cells. Oncotarget. 2018; 9(5):5876-5891. PMC: 5814181. DOI: 10.18632/oncotarget.23143. View

20.

Takes R, Strojan P, Silver C, Bradley P, Haigentz Jr M, Wolf G . Current trends in initial management of hypopharyngeal cancer: the declining use of open surgery. Head Neck. 2012; 34(2):270-81. DOI: 10.1002/hed.21613. View